ID   R6.5.D6.E9.B2
AC   CVCL_G148
SY   R6-5-D6
DR   CLO; CLO_0008719
DR   ABCD; ABCD_AH397
DR   ATCC; HB-9580
DR   BCRC; 60534
DR   Wikidata; Q54949057
RX   Patent=US5284931;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9580.
CC   Biotechnology: Was used to produce the monoclonal antibody enlimomab (BIRR-1) which is used in clinical trials in refractory rheumatoid arthritis and to reduce the incidence of acute rejection after kidney and liver allograft transplantations.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P05362; Human ICAM1/CD54.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 10
//
RX   Patent=US5284931;
RA   Springer T.A., Rothlein R., Marlin S.D., Dustin M.L.;
RT   "Intercellular adhesion molecules, and their binding ligands.";
RL   Patent number US5284931, 08-Feb-1994.
//